• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Delivering Better Gut Health Supplements

    Delivering Dietary Supplements that Exceed Consumer Expectations

    Green Business Network Seeks Comment on New Certification for Hemp-CBD Businesses

    Sweeteners Market Continues to Broaden with Cleaner Labels and Better Formulations

    Optimizing Gut Health: Unlocking the Gates to Well-Being
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health

    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status

    Nutritional Complex Evidenced to Reduce Preterm Birth

    Meta-analysis Determines HMB Supplementation Promotes Healthy Muscle Mass in Older Adults

    AHPA’s 9th Botanical Congress to Take Place May 24
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health

    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status

    Nutritional Complex Evidenced to Reduce Preterm Birth

    Meta-analysis Determines HMB Supplementation Promotes Healthy Muscle Mass in Older Adults

    AHPA’s 9th Botanical Congress to Take Place May 24
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health

    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status

    Nutritional Complex Evidenced to Reduce Preterm Birth

    Meta-analysis Determines HMB Supplementation Promotes Healthy Muscle Mass in Older Adults

    AHPA’s 9th Botanical Congress to Take Place May 24
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health

    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status

    Nutritional Complex Evidenced to Reduce Preterm Birth

    Meta-analysis Determines HMB Supplementation Promotes Healthy Muscle Mass in Older Adults

    First Day Life Shuts Down Children's Behavioral, Cognitive Health Claims Following Challenge
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Nutrition21, LLC

    Indena USA, Inc.

    Gencor

    Chenland Nutritionals Inc.

    Sabinsa Corporation
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Chenland Nutritionals Inc.

    Vesta Nutra

    Nutrition21, LLC

    KLK OLEO - Davos Life Science

    Indena USA, Inc.
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Confusion Over Cannabis & The Fate of CBD

    Fair and reasonable or not, FDA could very well be a major buzzkill in the CBD supplement sector.

    Confusion Over Cannabis & The Fate of CBD
    Related CONTENT
    • National Survey Suggests Consumer Knowledge of CBD is Highly Limited
    • ICYMI: What People Were Reading on NutraceuticalsWorld.com in March 2021
    • Supporting CBD Science: The Path to Claims
    • Mary Jane’s Botanicals: Unique Formulations Hand-Crafted with Premium Ingredients
    • CBD Toxicology Study Affirms Safety, No Liver Issues
    By Erik Goldman, Holistic Primary Care07.02.18
    “If you’re going to push the envelope, don’t be dumb about it.” That sums up attorney Ivan Wasserman’s most basic advice for dietary supplement companies selling cannibidiol (CBD) or any other cannabis-derived products.

    One could argue that from a regulatory viewpoint, CBD is the envelope. Anyone paying attention to this industry knows there are hundreds of supplement companies willing to push it. 

    This year’s Natural Products Expo West made plain the extent to which CBD has entered into and invigorated the supplement market. The practitioner channel is no exception: several major practitioner-only players, including Thorne Research and Designs for Health, have already launched cannabis/hemp-based products, and rumor has it that several others are following suit.

    Further, cannabis-specific companies, like Encore Life, have launched new practitioner-targeted CBD lines. And some wildly popular consumer-focused CBD brands like Charlotte’s Web are now marketing at integrative and functional medicine conferences alongside the well-established practitioner-facing nutraceutical companies. All of this is distinct from, though related to, the medical marijuana industry, which is also growing rapidly in states in which it is legal.

    In short, cannabis has a lot of people seeing green these days; except, of course, for the regulators—and a little drug company called GW Pharmaceuticals—who are definitely seeing red. The Federal government has shown every intention of spoiling the CBD supplement party, and GW is very likely to emerge the big winner.

    Seeing Green, Ignoring Red
    “Nothing is moving faster than CBD and cannabis,” said Mr. Wasserman, a partner with Amin Talati Upadhye. He has worked with several companies playing in the rapidly shifting CBD/cannabis space.

    Speaking at Holistic Primary Care’s recent Practitioner Channel Forum, he noted the cannabis category’s growth potential is more than matched by its regulatory complexity and its potential for oversteps, marketing misfires, and quality assurance nightmares.

    Exuberance about booming sales can easily woo companies to forget two essential rules: 1) don’t turn scientific communication into commercial speech; 2) don’t be false, misleading, or fraudulent in your marketing communications.

    In today’s turbo-charged CBD/cannabis space, Mr. Wasserman sees companies doing both.  Yes, there is a burgeoning body of medical research showing that CBD and other compounds derived from cannabis affect multiple physiological processes, and that they can offer benefits for people struggling with a wide range of physical and psychological conditions.

    But as with any supplement ingredient, scientific data are not a license to make disease claims. “Commercial speech”—even if based on good science—is rampant in the cannabis/CBD market, more so on the consumer/retail side than in the practitioner channel, where marketers are more cautious.

    But on both sides of that increasingly porous divide, there’s a gold rush around CBD and cannabis. Some marketers are either forgetting that disease-focused claims are illegal, or in the spirit of marijuana’s outlaw status, they’re choosing to cross the line.

    And let’s face it: at the federal level, cannabis is still illegal. Todd Harrison, a partner with Venable LLP, who also spoke at the Forum, said the bottom line is that the Drug Enforcement Administration (DEA) still considers marijuana to be a Schedule 1 narcotic, despite any and all other state-level laws that rule otherwise. And by “marijuana,” the DEA means all parts of the Cannabis sativa plant—the seeds, the leaves, the stalks, the resin, everything.

    Strange Politics
    Despite all industry arguments to the contrary, “Hemp” and Cannabis are the same in the eyes of the law. The sole difference is the relative content of tetrahydrocannabinol (THC). To be recognized as “industrial hemp” the plant—and any extracts derived from it—must contain no more than 0.3% THC on a dry weight basis.

    The Hemp Industries Association (HIA) recently tried and failed to change the DEA’s classifications. Mr. Harrison explained that the HIA sought to have hemp extracts delisted as controlled substances on the grounds that the DEA’s classification was not consistent with the definition or intent of the definition of marijuana in the original Controlled Substances Act, and that it conflicted with industrial hemp provisions in the Agricultural Act (aka the Farm Bill). The 9th Circuit Court did not agree. “Basically, they punted,” Mr. Harrison said.

    In April, Senator Mitch McConnell (R-KY) introduced the Hemp Farming Act of 2018 into the Senate, with an identical bill brought to the House. The bill would exempt hemp (containing less than 0.3% THC) from the federal definition of “marijuana” under the Controlled Substances Act. It would give state governments and Native American tribal authorities primary regulatory authority over production of hemp, and the opportunity to submit proposals to the U.S. Secretary of Agriculture detailing how they would regulate hemp production and distribution.
    The bill induced euphoria among many in the hemp industry, leading some to canonize the arch-conservative Sen. McConnell as the new patron saint of herb.

    But as with just about everything else on today’s legislative scene, the Hemp Farming Act is a political football. Senator Chuck Grassley (R-IA) opted to break ranks with Sen. McConnell and introduced an amendment that would explicitly exclude “cannabinoids,”  “extracts,” and “derivatives” from the Farm Bill’s definition of industrial hemp; that basically means CBD. Sen. Grassley’s amendment was shot down in the Senate committee hearings, but the Iowa senator said he remains committed to pushing for these exclusions.

    Mr. Harrison, who works in D.C., believes Sen. McConnell’s hemp bill will ultimately pass. It has bipartisan support—Senate minority leader Chuck Schumer (D-NY) is on board—and won’t likely run into any opposition from the Oval Office. “I don’t think Trump cares one way or the other.”

    Drug or Dietary Supplement?
    So, yes, hemp will likely be de-scheduled. But that won’t change the game much for companies marketing CBD or any hemp-derived substances as dietary supplements. First, CBD is derived from the resin of the cannabis plant, not the seeds, so any company claiming to have “seed-derived CBD oil” is selling hemp seed oil with added CBD.

    And since, by DEA statutes, the resin counts as “marijuana,” CBD counts as “marijuana” despite the wishes of the cannabis industry and its many millions of customers. Further, low-THC hemp strains tend to produce very little CBD-containing resin, which means that most CBD will be coming from straight-up cannabis, not “hemp.”

    Second, while Sen. McConnell’s bill would redefine hemp as distinct from marijuana, it says nothing about the freedom to market hemp-derived products, despite what the marijuana lawyers will tell you. If it all sounds like a big game of semantics, it is. But the words and definitions are delineating the terms of engagement in the market, and the positions that regulators are going to take.

    Mr. Harrison said there’s currently no legitimate way to claim CBD is a dietary supplement. The FDA has made it very clear that it does not consider CBD to be a dietary supplement, based on the fact that GW Pharmaceuticals had filed Investigational New Drug applications for its CBD-based drug products years back in 2014. The company’s Sativex (Nabiximols)—an oral spray for use to treat pain and spasticity in people with multiple sclerosis—was approved as a drug in the U.K. in 2010.

    FDA approved the company’s Epidiolex product as a prescription form of CBD for childhood epilepsy at the end of June.

    Basically, the FDA has taken the position that since GW has developed CBD as a prescription drug, it cannot therefore be sold as a supplement unless a company can definitively prove that it was marketing CBD as a dietary supplement or conventional food before GW’s INDs were authorized. That, according to Mr. Harrison, is going to be a difficult feat.

    With GW’s Epidiolex approved as a prescription drug, one could expect tougher enforcement action against companies selling CBD as a supplement. FDA probably won’t take issue with companies selling hemp seed or hemp seed oil as foods, according to Mr. Harrison.

    It will be much harder to make the case that hemp stalks, leaves or flowers—which contain the CBD-rich resin—are or ever were a food source for humans.

    Fair and reasonable or not, FDA could very well be a major buzzkill in the CBD supplement sector. Mr. Harrison expects the agency will feel a strong “duty to enforce” once it grants drug approval for Epidiolex. “If the FDA doesn’t enforce, they will have made a mockery of the Food, Drug and Cosmetic Act.”

    In the meantime, sales of CBD are booming. Retailers speaking at a CBD Summit that preceded Expo West this year noted that CBD products are moving off the shelves as fast or even faster than more common—and less controversial—supplements like omega-3s or probiotics.

    The surge is driven in part by consumers’ fears that once Epidiolex is approved, CBD will no longer be freely available without prescription.

    Practitioner Perspectives
    How do medical professionals feel about cannabis and CBD? According to Holistic Primary Care’s 2018 clinician survey, the attitudes are generally positive, at least among holistic and functional medicine practitioners. Many are already on board with CBD, and others are interested and willing to learn.

    The survey, which fielded from March through May of this year, and obtained responses from 469 practitioners, included the following question: “In recent years, interest in cannabis and cannabis-derived substances like CBD has soared among researchers, clinicians, and the general public. Which statement best describes your views on Cannabis and CBD?”
    • 56% chose “CBD & cannabis-derived substances have therapeutic value and should be used more widely”;
    • 26% chose “CBD & cannabis have clinical value, but should only be available by prescription from a licensed practitioner”;
    • 17% chose “I am not yet convinced that CBD or cannabis have therapeutic value, but I am open to seeing further research”;
    • 2% chose “Neither cannabis nor CBD have therapeutic benefits; they are drugs of abuse and do not belong in any legitimate medical practice.
    The MD subset (33% of total cohort) were somewhat less likely than the general cohort to advocate for wide use of CBD and cannabis derivatives (47% vs 56%), and somewhat more inclined to support Rx-only status (34% vs 26%).

    But overall, acceptance of CBD and, to a lesser extent medical cannabis, as legitimate medicine is quite high among today’s clinicians. Only a small percentage sees these substances exclusively as noxious drugs of abuse. One quarter (24%) of respondents said they are already dispensing or recommending CBD but not cannabis itself. Only 1% are recommending or dispensing cannabis but not CBD.

    Nearly one-third (29%) are recommending or dispensing both CBD and cannabis, and 28% are considering the possibility of recommending or dispensing CBD or other cannabis products.
    Are practitioners who dispense or recommend CBD supplements crossing legal lines? They could be. While regulators are generally unwilling to interfere with practitioner-patient relationships, or challenging the “learned intermediary” status that medical professionals hold, they might feel emboldened to do so in the case of cannabis-related products, especially in the wake of a newly approved Rx-only product.

    Mr. Harrison believes physicians are taking some legal risk in “marketing an ingredient the DEA considers a controlled substance.” He added that companies selling these products to and through doctors are also taking calculated risks.

    Whether the laws are reasonable or not, whether they serve the best interests of practitioners or patients is certainly up for debate. What’s not debatable is the public’s interest in and desire for freely accessible non-Rx forms of CBD. But from a practical point of view, what really matters is the scope and intensity of FDA and DEA enforcement of existing statutes around CBD and cannabis.

    It remains to be seen whether federal agencies will continue to permit widespread sale of non-Rx CBD as dietary supplements, and frankly whether they have the budgets and personnel needed to do much more than issue a lot of stern warning letters. 


    Erik Goldman
    Holistic Primary Care

    Erik Goldman is co-founder and editor of Holistic Primary Care: News for Health & Healing, a quarterly medical publication reaching about 60,000 physicians and other healthcare professionals nationwide. He is also co-producer of the Practitioner Channel Forum, the nation’s leading conference focused on opportunities and challenges in the practitioner segment of the dietary supplement industry. 
    Related Searches
    • Probiotics
    • Healthcare
    • Dietary Supplements
    • Herb
    Related Knowledge Center
    • Herbs & Botanicals
    • Medical Nutrition
    • Dietary Supplements
    Suggested For You
    National Survey Suggests Consumer Knowledge of CBD is Highly Limited National Survey Suggests Consumer Knowledge of CBD is Highly Limited
    ICYMI: What People Were Reading on NutraceuticalsWorld.com in March 2021 ICYMI: What People Were Reading on NutraceuticalsWorld.com in March 2021
    Mary Jane’s Botanicals: Unique Formulations Hand-Crafted with Premium Ingredients Mary Jane’s Botanicals: Unique Formulations Hand-Crafted with Premium Ingredients
    Supporting CBD Science: The Path to Claims Supporting CBD Science: The Path to Claims
    CBD Toxicology Study Affirms Safety, No Liver Issues CBD Toxicology Study Affirms Safety, No Liver Issues
    Two Science Experts Join Open Book Extracts as Strategic Corporate Advisors Two Science Experts Join Open Book Extracts as Strategic Corporate Advisors
    Post COVID-19: A New World of Health & Nutrition Opportunities Post COVID-19: A New World of Health & Nutrition Opportunities
    Folium Biosciences Submits Novel Food Application for CBD in U.K. Folium Biosciences Submits Novel Food Application for CBD in U.K.
    ICYMI: What People Were Reading on NutraceuticalsWorld.com in February 2021 ICYMI: What People Were Reading on NutraceuticalsWorld.com in February 2021
    FTC Finalizes First Administrative Actions Against CBD Marketing Claims FTC Finalizes First Administrative Actions Against CBD Marketing Claims
    Open Book Extracts: Innovating for Tomorrow’s Market Open Book Extracts: Innovating for Tomorrow’s Market
    Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow
    Indena Becomes First Company in Italy Authorized to Produce CBD Indena Becomes First Company in Italy Authorized to Produce CBD
    CBD Pharmacokinetics Study Compares Absorption Rate of Various Product Formats CBD Pharmacokinetics Study Compares Absorption Rate of Various Product Formats
    Schrader-Griffith Bill to Regulate CBD Re-Introduced to 117th Congress Schrader-Griffith Bill to Regulate CBD Re-Introduced to 117th Congress

    Related Columns

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Regulations
      Medically Necessary Foods: Pricing & Reimbursement Considerations

      Medically Necessary Foods: Pricing & Reimbursement Considerations

      Navigating the large and growing medical foods market requires understanding key dynamics.
      By Gregory Stephens, Windrose Partners 04.08.21

    • Dietary Supplements | Regulations
      Dual Tracking of New Ingredients as Dietary Supplements and Drugs

      Dual Tracking of New Ingredients as Dietary Supplements and Drugs

      It’s possible to develop novel ingredients for both the dietary supplement and drug markets, but timing is important and there are gray areas.
      By Todd Harrison, Venable 04.08.21

    • Dietary Supplements | Probiotics & Prebiotics | Regulations | World Markets
      Probiotics & Prebiotics: The EU Ban is Shaking

      Probiotics & Prebiotics: The EU Ban is Shaking

      Some countries have not accepted the European Commission’s limitations on the term ‘probiotic’ and have implemented their own interpretations.
      By Joerg Gruenwald, analyze & realize ag 04.08.21


    • Herbs & Botanicals | Research
      Botanical Research: Medicinal Mushrooms, Bacopa & the Brain, Green Tea & Depression

      Botanical Research: Medicinal Mushrooms, Bacopa & the Brain, Green Tea & Depression

      AHPA compiles recent research on botanicals and plant compounds published in peer-reviewed journals.
      By Holly Johnson, PhD, American Herbal Products Association (AHPA) 04.08.21

    • Dietary Supplements | Healthcare Trends | Immune Function | Medical Nutrition | Vitamins
      Biden COVID Response Plan Overlooks Nutrition

      Biden COVID Response Plan Overlooks Nutrition

      Our field has a unique opportunity to demonstrate the merits of our products, and the principles and philosophies behind them.
      By Erik Goldman, Holistic Primary Care 03.03.21

    • Consumer Trends | Dietary Supplements | Herbs & Botanicals | Quality & Safety
      Open Book Extracts: Innovating for Tomorrow’s Market

      Open Book Extracts: Innovating for Tomorrow’s Market

      Dave Neundorfer has a clear vision to deliver pure and consistent cannabinoids for a range of product types.
      By Sheldon Baker 03.03.21


    • Consumer Trends | Dietary Supplements | Herbs & Botanicals | Regulations
      The Evolution of Insurance for Hemp & CBD

      The Evolution of Insurance for Hemp & CBD

      Delta-8-THC is the latest wrinkle in the hemp-derived products market.
      By Chris Morey, Bolton & Company 03.03.21

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Regulations
      The Off-Label On Ramp

      The Off-Label On Ramp

      With an expanding base of clinical research supporting nutritional interventions, off label use of dietary supplements and medical foods is likely to grow.
      By Gregory Stephens, Windrose Partners, and Sheila Campbell, PhD, RD 01.19.21

    • Dietary Supplements | Healthcare Trends | Immune Function | Regulations
      ‘Follow the Science’ Often Misses the Mark with Nutrition

      ‘Follow the Science’ Often Misses the Mark with Nutrition

      The mantra too often ignores common sense approaches to improving health and quality of life.
      By Todd Harrison, Venable 01.19.21


    • Dietary Supplements | Herbs & Botanicals | Regulations | World Markets
      CBD in Europe: News from the Front

      CBD in Europe: News from the Front

      A recent decision by the Court of Justice of the European Union has restored CBD’s status, and with it, the prospects of the entire industry.
      By Joerg Gruenwald, analyze & realize ag 01.19.21

    • Cardiovascular Health | Herbs & Botanicals | Immune Function | Research | Weight Management/Weight Loss
      Botanical Research: Botanicals & Immunity, Kava Challenges, Turmeric Therapeutics and More

      Botanical Research: Botanicals & Immunity, Kava Challenges, Turmeric Therapeutics and More

      AHPA compiles recent research on botanicals and plant compounds published in peer-reviewed journals.
      By Holly Johnson, PhD, American Herbal Products Association (AHPA) 01.19.21

    • Delivery & Dosage Technologies | Dietary Supplements | Herbs & Botanicals | Quality & Safety
      The Advantages of Organic, Broad Spectrum Hemp

      The Advantages of Organic, Broad Spectrum Hemp

      Mike Hennesy, Wana Brands, discusses the company’s new gummies, innovation, and continuing market evolution.
      By Sheldon Baker 12.04.20


    • Dietary Supplements | Regulations
      Insurance Rates Have Been at an All-Time Low, But a Hard Market is Coming

      Insurance Rates Have Been at an All-Time Low, But a Hard Market is Coming

      Companies can be prepared by being thorough and transparent while going through insurance policy renewals.
      By Chris Morey, Bolton & Company 12.04.20

    • Dietary Supplements | Regulations
      A Business Perspective on Protecting Confidential Information: The NDA

      A Business Perspective on Protecting Confidential Information: The NDA

      Along with taking precautions in providing access to confidential information, a non-disclosure agreement can be a great way to protect your business.
      By Gregory Stephens, Windrose Partners 11.09.20

    • Dietary Supplements | Healthcare Trends | Immune Function | Regulations | Research | Vitamins
      Using All the Tools to Improve Public Health

      Using All the Tools to Improve Public Health

      Industry needs to make a stand in compelling authorities to communicate the value of nutrition and dietary supplementation.
      By Todd Harrison, Venable 11.09.20

    Trending
    • NSF/Harvard Study Finds Deterenol, Other Stimulants In Sports & Weight Loss Supplements
    • Several Studies Evaluate Role Of Vitamin D In COVID-19 Outcomes
    • Study Investigates Probiotics Impact On COVID-19 Remission Rates
    • Focus, Endurance, Resilience: The Esports Community Is Seeking Out Supplements
    • New Study Confirms Vegan Vitamin D3 Ingredient Is Bioavailable
    Breaking News
    • Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health
    • CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status
    • Nutritional Complex Evidenced to Reduce Preterm Birth
    • Meta-analysis Determines HMB Supplementation Promotes Healthy Muscle Mass in Older Adults
    • AHPA’s 9th Botanical Congress to Take Place May 24
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Optimizing Gut Health: Unlocking the Gates to Well-Being
    • Sweeteners Market Continues to Broaden with Cleaner Labels and Better Formulations
    • Green Business Network Seeks Comment on New Certification for Hemp-CBD Businesses
    • Delivering Dietary Supplements that Exceed Consumer Expectations
    • Delivering Better Gut Health Supplements
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health
    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status
    Nutritional Complex Evidenced to Reduce Preterm Birth
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies to Sponsor and Exhibit at the North American Pultrusion Conference 2021
    Barentz Expands Canadian CASE Team
    Shepherd Color Company Opens Sales Office in China
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CMS Establishes New Payment for Pelvalon’s Eclipse System
    Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy
    Resonetics Leases New Manufacturing Space in Costa Rica
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    Ascendia Pharmaceuticals Poised for Expansion
    Bora Pharmaceuticals Adds Roller Compaction Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Revlon Unveils New Fragrances Featuring Megan Thee Stallion & Sofia Carson
    Henkel Management Board Welcomes Wolfgang König
    Mielle Organics Gets a Major Investment
    Happi

    Latest Breaking News From Happi

    Nature’s Beauty Debuts Vegan Natural Body Care at Walgreens
    Estée Lauder Expands Beautiful Fragrance Collection
    The Honest Company Files for IPO
    Ink World

    Latest Breaking News From Ink World

    SE-DA Invests in Kornit Presto S
    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Iron Oxide Pigments Market to Register 4.7% CAGR from 2021 to 2028: GVR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Dantex elevates Joseph Sanchez to digital business development manager
    Mactac's Kevin Clunie joins TLMI panel
    MacDermid announces two new global sales roles
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Precision Textiles Offers Biodegradable Medical Fabric
    Northshore Launches Megamax Briefs in New Colors
    Essity Acquires Distribution Rights to Sorbact in Australia and New Zealand
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    Google Executive Joins SeaSpine's Board of Directors
    HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Tive Multi-sensor Tracker Solo 5G Relies on Sensirion SHT33
    VTT in 2020: Successful Year Despite Globally Challenging Times
    Lux Research: 3D Printing Market to Reach $51 Billion in 2030

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login